Seegene

Seegene Assets per Share

The Total Assets per Share of Seegene (096530.KQ) as of Oct 29, 2026 is 26,774.42 KRW. In the previous year, Total Assets per Share was 26,113.22 KRW — a change of 2.53% (higher).

Assets per Share

26,774.42KRW

YoY

2.53%

Last updated:

Total Assets per Share of Seegene is 2025 26,774.42 KRW. Total Assets per Share of Seegene was 2024 26,113.22 KRW. It decreases by 2.53% higher compared to the previous year.

The Seegene Assets per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Assets per Share
Date
Assets per Share
Jan 1, 2018
3,548.97 KRW
Jan 1, 2019
4,240.31 KRW
Jan 1, 2020
23,714.73 KRW
Jan 1, 2021
32,275.80 KRW
Jan 1, 2022
30,132.17 KRW
Jan 1, 2023
27,113.58 KRW
Jan 1, 2024
26,113.22 KRW
Jan 1, 2025
26,774.42 KRW
The Seegene Assets per Share history
YEARAssets per ShareYoY
26,774.42KRW+2.53%
26,113.22KRW-3.69%
27,113.58KRW-10.02%
30,132.17KRW-6.64%
32,275.80KRW+36.10%
23,714.73KRW+459.27%
4,240.31KRW+19.48%
3,548.97KRW-0.63%
3,571.39KRW-20.60%
4,498.19KRW+6.99%
4,204.18KRW+40.15%
2,999.69KRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Seegene Stock analysis

What does Seegene do? Seegene, Inc. generates revenue through the manufacturing and distribution of molecular diagnostics and reagents. The company offers infectious pathogens inspection products, including those for allergic respiratory pathogens, sexually transmitted diseases, and human papilloma virus (HPV), alongside drug resistance, single nucleotide polymorphisms (SNP), and somatic mutation cancer inspection products. It also provides automatic real-time detection instruments under the brand names Seeplex, Anyplex, and Magicplex. The firm serves both domestic and overseas markets with these products. The primary customers for Seegene's products are healthcare providers and laboratories requiring diagnostic solutions. The company's product portfolio targets specific medical needs such as infectious disease testing and cancer diagnostics. Its brands Seeplex, Anyplex, and Magicplex are used across various diagnostic applications, including respiratory and sexually transmitted disease testing. The firm's focus on molecular diagnostics positions it within the healthcare sector for specialized testing services. Seegene's revenue streams are derived from the sale of its branded diagnostic products and instruments. The company's domestic and overseas market distribution strategy supports its business model, with Seeplex, Anyplex, and Magicplex serving as key product lines. The firm's offerings cater to the growing demand for accurate and efficient molecular diagnostic solutions in healthcare settings. Seegene is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Seegene stock

Total Assets per Share of Seegene is 26,774.42 KRW in 2025.

Total Assets per Share of Seegene changed from 26,113.22 KRW to 26,774.42 KRW, representing a 2.53% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Total Assets per Share Seegene since 2006 – with annual values, charts, and detailed analysis.

Assets per share divides total assets by shares outstanding, indicating the total resource base backing each share of stock.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Other — Seegene

All Key Metrics — Seegene